Supply Chain

Marathon Pharmaceuticals' $89,000 price tag for its newly approved Duchenne muscular dystrophy drug has drawn criticism from many lawmakers, including Sen. Bernie Sanders, I-Vt., reports CBS New York.

Arlington-based Texas Health Resources recently expanded its partnership with Inventory Optimization Solutions.

Integra LifeSciences Holdings Corp. will purchase Johnson & Johnson's Codman neurosurgery business for $1.05 billion, reports Reuters.

Merck on Tuesday halted a late-stage clinical trial of its Alzheimer's drug verubecestat after an independent study discovered the treatment had "virtually no chance" of proving effective, reports CNN.

Many health systems struggle to standardize products and contract prices across their facilities.

"Reciprocal approval" would allow the Food and Drug Administration to automatically sign off on new drugs already approved in other countries. While some healthcare players believe this strategy could help lower drug prices and give patients access to treatments sooner,…

Some pharmaceutical executives fear President Donald Trump's call for a deregulated Food and Drug Administration would make it harder for drugmakers to gain insurance coverage for new treatments, reports Reuters.

Supply chain improvements create better quality and promote patient safety, according to a new survey from Cardinal Health.

Skin creams and ointments prescribed by dermatologists cost more than those prescribed by a family medicine or primary care physician, according to a new study in the Journal of the American Academy of Dermatology.

Marlborough, Mass.-based Hologic will purchase the medical aesthetics company Cynosure for $1.65 billion, reports Reuters.